Inogen, Inc.

NASDAQ:INGN

Medical - Devices

Healthcare
$5.57 +0.71%

+$0.05 today

Market cap
$144.83M
Beta
1.59
P/E (TTM)
-7.0
EPS (TTM)
-$0.91
52W Low $5.34High $9.13

Volume 0.19M

Average 0.33M

INGN Deferred Tax Liabilities

Taxes owed in future periods because of timing differences between accounting and tax rules.

Inogen, Inc.NASDAQ: INGN

Deferred Tax Liabilities · Q1 FY2026 · quarter ended Mar 2026

Deferred tax liabilities falls 11.3% from a year ago

Deferred tax liabilities stood at $6.57M at the end of Q1 FY2026, down 11.3% from a year earlier and down 2.6% from the prior quarter.

Context

  • Deferred tax liabilities amounted to 2.3% of total assets at the end of Q1 FY2026, down 0.1 pp from a year earlier.
  • Deferred tax liabilities increased in 1 of the last 3 fiscal years.

What to watch

Whether deferred tax liabilities keeps falling in the next quarterly balance sheet after a -11.3% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$6.57M-2.6% QoQ
Last fiscal yearDec 2025
$6.75M-2.9% YoY
Year agoMar 2025
$7.41M-11.3% since
Deferred Tax Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-11.3%——
1 year-2.9%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Deferred Tax Liabilities history

USD · from the balance sheet

Latest · FY2025
6.75M USD
Year-over-year change
-2.9%

Deferred Tax Liabilities vs competitors

How INGN compares with its peers on the latest reported figures

  • INGN's Mar 2026 deferred tax liabilities of $6.57M is the highest of the 11 companies compared; the peer median is $0.
  • Its year-over-year change of -11.3% is the highest of 3, against a peer median of -54.2%.
  • Deferred tax liabilities amounts to 2.3% of total assets for INGN, versus a peer median of 0.0%.
INGN Competitors Peer median
Deferred Tax Liabilities for INGN and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
INGNInogen, Inc.Mar 2026$6.57M -11.3%—2.3%
CATXPerspective Therapeutics, Inc.Mar 2026$1.7M -31.8%—0.4%
NNOXNano-X Imaging Ltd.Dec 2025$600K -76.7%-43.5%0.4%
SGHTSight Sciences, Inc.Mar 2026$0 ——0.0%
EPRXEupraxia Pharmaceuticals Inc.Mar 2026$0 ——0.0%
SIShoulder Innovations, Inc.Mar 2026$0 ——0.0%
QTRXQuanterix CorporationMar 2026$0 —-4.3%0.0%
HCATHealth Catalyst, Inc.Mar 2026$0 ——0.0%
HSDTSolana CompanyMar 2026$0 ——0.0%
OMOutset Medical, Inc.Mar 2026$0 ——0.0%
SNWVSANUWAVE Health, Inc.Mar 2026$0 ——0.0%
Peer median (excluding INGN) $0-54.2%-23.9%0.0%

Competitors are the stored peer set for INGN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents235.52M187.01M125.49M113.8M103.73M
Short-term Investments9.99M02.98M015.85M
Net Receivables25.8M64.35M42.91M30.1M38.86M
Inventory31.87M34.09M21.84M24.81M25.97M
Other Current Assets019.19M13.85M16.74M13.89M
Total Current Assets329.19M304.65M207.07M185.45M198.3M
Property, Plant & Equipment (Net)63.84M64.92M70.65M62.7M52.86M
Goodwill32.98M32.85M10.06M9.47M10.7M
Intangible Assets60.15M177K34.59M30.49M30.76M
Long-term Investments00000
Tax Assets00000
Other Non-current Assets3.36M2.45M3.83M8.08M6M
Total Non-current Assets160.33M100.4M119.13M110.73M100.33M
Total Assets489.51M405.04M326.19M296.19M298.63M
Account Payables10.26M18.24M13.45M16.62M20.26M
Short-term Debt00000
Tax Payables561K492K27K142K183K
Deferred Revenue8.57M8.88M7.98M6.65M5.5M
Other Current Liabilities6.48M7.79M19.63M22.74M10.12M
Total Current Liabilities61.51M65.35M72.5M76.69M63.54M
Long-term Debt00000
Deferred Tax Liabilities008.54M6.95M6.75M
Deferred Revenue (Non-current)11.86M10.4M8.23M5.75M3.6M
Other Non-current Liabilities22.63M12.12M13.85M16.35M18.19M
Total Non-current Liabilities57.77M42.29M48.89M45.64M42.86M
Total Liabilities119.29M107.64M121.38M122.33M106.39M
Common Stock23K23K23K24K27K
Retained Earnings69.27M(14.5M)(116.95M)(152.84M)(175.58M)
Accumulated OCI1.47M(243K)1.23M(1.5M)4.24M
Other Stockholders Equity00000
Minority Interest00000
Total Equity370.23M297.41M204.81M173.86M192.23M
Total Debt26.67M23.28M21.92M19.41M17.48M
Net Debt(208.85M)(163.74M)(103.57M)(94.39M)(86.25M)

Inogen, Inc.

NASDAQ:INGN

Intrinsic Alpha fair value

Locked

Current Price

$5.57

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.